Potential of oculomics in retinal diseases discussed at ASRS

In this video, Vivienne S. Hau, MD, PhD, of Kaiser Permanente Bernard J. Tyson School of Medicine, discussed the emergence of oculomics, which was a topic at this year’s American Society of Retina Specialists annual meeting.
Hau explained the use of oculomics, which combines current eye imaging techniques such as OCT angiography and fundus photos with AI. This may help retina specialists identify biomarkers earlier than before, possibly resulting in earlier treatment of retinal diseases.
“At this meeting, there were a lot of talks looking at biomarkers that were recently found and are

Real-world data emerging on dry AMD, geographic atrophy treatments

Major topics of discussion at this year’s American Society of Retina Specialists annual meeting included real-world data on the treatment of geographic atrophy in dry age-related macular degeneration.
“This was huge this year because now we actually have medications that can slow down the progression of geographic atrophy and macular degeneration,” Vivienne S. Hau, MD, PhD, of Kaiser Permanente Bernard J. Tyson School of Medicine, told Healio in an interview. “We even have better imaging and understanding with new biomarkers.”

PMOS may raise risk for atherosclerotic heart disease

Polyendocrine metabolic ovarian syndrome was associated with increased risk for atherosclerotic cardiovascular disease events and the association was only partially mediated by the presence of baseline comorbidities, researchers reported.
Polyendocrine metabolic ovarian syndrome (PMOS), the new proposed name for polycystic ovary syndrome (PCOS), may be an independent predictor of ASCVD events, including coronary artery disease, cerebrovascular disease and peripheral artery disease, according to data published in The Lancet Obstetrics, Gynaecology, & Women’s Health.
“Women with

Statin uptake slow among people with new-onset diabetes

SCOTTSDALE, Ariz. — Contrary to guidelines, one in three eligible patients with new-onset diabetes do not receive a prescription for statin therapy within 1 year of diagnosis, a speaker reported.
Many patients with new-onset diabetes aged 40 to 75 years who may benefit from statin therapy do not receive it within 1 year, and among those who do, prescription may take months after initial diagnosis, according to study findings presented at the American Society for Preventive Cardiology Congress on CVD Prevention.
“Diabetes increases [atherosclerotic] CVD risk by fourfold, and statins

Do GLP-1s belong in dermatology? Evidence suggests a growing role

GLP-1 receptor agonists are best known for treating type 2 diabetes and obesity, yet a growing body of evidence suggests their benefits may extend well beyond metabolic disease to dermatologic indications.
“GLP-1s are the surprise anti-inflammatory that no one saw coming,” Mona Shahriari, MD, FAAD, associate clinical professor of dermatology at Yale University School of Medicine, told Healio. “They do much more than help with weight loss. They also reduce systemic inflammation.”
Interest in GLP-1s’ dermatologic potential accelerated this year after the landmark TOGETHER-PsO trial showed that

Metabolic improvements cut MASLD-linked colorectal neoplasia risk

Patients with metabolic dysfunction-associated steatotic liver disease who improved their metabolic health after polypectomy significantly lowered their risk for metachronous advanced colorectal neoplasia, study results showed.
Findings also suggested that those with the highest metabolic burden or any advanced colorectal neoplasia at baseline benefited most from lifestyle interventions to reduce this risk.
“Postpolypectomy care should extend beyond scheduling the next surveillance colonoscopy,” Han-Mo Chiu, MD, PhD, attending physician and clinical professor in the department of internal

Existing dry eye questionnaires may not apply to children

Dry eye symptoms in children may not be adequately captured by the Dry Eye Questionnaire or a modified version of the Ocular Surface Disease Index, according to a study published in Optometry and Vision Science.
“Interestingly, especially associated with prolonged screen time, more recent studies have concluded that the prevalence of dry eye disease in children is actually close to that in adults,” Yi Pang, OD, PhD, FAAO, associate dean for research at Illinois College of Optometry, and colleagues wrote. “Given the increasing prevalence of dry eye disease in children, there

Smoking cessation program could avert thousands of cancer deaths

Implementation of a nationwide tobacco cessation program could save more than 60,000 lives and $12 billion in healthcare costs in 10 years.
A dynamic evaluation of the Tobacco Research and Treatment Program at The University of Texas MD Anderson Cancer Center also showed that if healthcare institutions across the country established the same protocols, nearly 290,000 life years could be gained over a decade.
“Tobacco treatment should be perceived as cancer treatment,” George Kypriotakis, PhD, assistant professor in the department of behavioral science at UT MD Anderson, told Healio. “Tobacco

Patients’ interviews highlight gravity of transitions to dialysis

Patients described transitions to dialysis as “traumatic” and “chaotic,” according to study data published in the American Journal of Kidney Diseases.
About 30% of patients with incident kidney failure experience an “optimal start,” defined by CMS as preemptive transplant, home dialysis or in-center hemodialysis with arteriovenous access, according to Megan Urbanski, PhD, MSW, assistant professor of surgery in the division of transplantation at Emory University School of Medicine, and colleagues.
To better understand patient experiences during the transition

Be prepared to help with affordability of diabetes care

Patients with diabetes, especially type 1 diabetes or insulin-dependent type 2 diabetes, need regular access to care, and in 2026, that has become challenging for many.
Changes to Medicaid caused many patients to lose their insurance coverage, rising costs of goods such as food and gasoline have led some patients to reduce their spending on healthcare, and crackdowns related to immigration status have led some patients to stop coming to public places such as doctors’ offices.
Healio | Endocrine Today Editorial Board Member Anne L. Peters, MD, professor of medicine at Keck School of Medicine of